Description
The Bacterial Lipid Nanodiscs Platform is a technology developed by Los Alamos National Laboratory that provides a new way to study entire bacterial membranes in a controlled, nanoscale format derived directly from native lipid extracts. This platform offers a safer alternative to handling live high-risk pathogens while preserving the biological context that drives meaningful insights for vaccine design and antimicrobial discovery. The key advantages of this platform include providing membrane-like structures using native bacterial lipids, avoiding the safety challenges of handling live pathogens, and offering a broader and more realistic lipid environment than synthetic nanodiscs. The potential market applications of this technology include life sciences research, vaccine development, drug discovery, diagnostics, and biodefense research.
Some of the key features of this technology are:
• Provides membrane-like structures using native bacterial lipids
• Avoids the safety challenges of handling live pathogens
• Offers a broader and more realistic lipid environment than synthetic nanodiscs
• Enables improved assessment of membrane antigens and immune responses
• Supports analysis of diverse bacterial species using a unified workflow
• Creates consistent nanoscale particles suitable for research and development settings
Attached files
Contact
Caleb Ledgerwood